Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy

NCT02204098 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Breast Carcinoma
Malignant Neoplasm of Breast

Interventions

BIOLOGICAL: Mammaglobin-A DNA Vaccine
PROCEDURE: Optional biopsy

Sponsor

Washington University School of Medicine

Collaborators

Rising Tide Foundation
United States Department of Defense